Literature DB >> 24648135

Mortality from diabetes mellitus, 2004 to 2008: A multiple-cause-of-death analysis.

Jungwee Park1, Paul A Peters1.   

Abstract

Using multiple-cause-of-death data, this study examines diabetes mellitus as a cause of mortality. During the 2004-to-2008 period, diabetes mellitus was listed as either the underlying cause or a contributing cause of 119,617 deaths. It was more than twice as likely to be a contributing than the underlying cause of death. When it was identified as the underlying cause of death, diabetes mellitus was rarely the only cause. The diabetes mellitus mortality rate was relatively high among males, older individuals, and people living in lower-income neighbourhoods. Provincial/Territorial differences in rates of death from diabetes mellitus were considerable. When diabetes mellitus was the underlying cause of death, cardiovascular diseases were listed as a contributing cause most often, and when diabetes mellitus was a contributing cause, cardiovascular diseases were most likely to be the underlying cause.

Entities:  

Keywords:  Cardiovascular diseases; comorbidity; data linkage; death certificates; socio-economic factors; vital statistics

Mesh:

Year:  2014        PMID: 24648135

Source DB:  PubMed          Journal:  Health Rep        ISSN: 0840-6529            Impact factor:   4.796


  7 in total

1.  The addition of vildagliptin to metformin prevents the elevation of interleukin 1ß in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, open-label study.

Authors:  Arwa Younis; Dana Eskenazi; Ronen Goldkorn; Jonathan Leor; Nili Naftali-Shani; Enrique Z Fisman; Alexander Tenenbaum; Ilan Goldenberg; Robert Klempfner
Journal:  Cardiovasc Diabetol       Date:  2017-05-22       Impact factor: 9.951

2.  Multiple cause of death analysis in multiple sclerosis: A population-based study.

Authors:  Katharine Harding; Feng Zhu; Mohammed Alotaibi; Thomas Duggan; Helen Tremlett; Elaine Kingwell
Journal:  Neurology       Date:  2020-01-13       Impact factor: 9.910

3.  Receptor for advanced glycation end as drug targets in diabetes-induced skin lesion.

Authors:  Xiang-Fang Chen; Wei Tang; Wei-Dong Lin; Zi-Yu Liu; Xiao-Xiao Lu; Bei Zhang; Fei Ye; Zhi-Min Liu; Jun-Jie Zou; Wan-Qing Liao
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

4.  Multiple causes of death analysis of chronic diseases: the example of diabetes.

Authors:  Ugo Fedeli; Giacomo Zoppini; Carlo Alberto Goldoni; Francesco Avossa; Giuseppe Mastrangelo; Mario Saugo
Journal:  Popul Health Metr       Date:  2015-08-25

5.  Metformin Induces Cell Cycle Arrest, Reduced Proliferation, Wound Healing Impairment In Vivo and Is Associated to Clinical Outcomes in Diabetic Foot Ulcer Patients.

Authors:  Fatima Ochoa-Gonzalez; Alberto R Cervantes-Villagrana; Julio C Fernandez-Ruiz; Hilda S Nava-Ramirez; Adriana C Hernandez-Correa; Jose A Enciso-Moreno; Julio E Castañeda-Delgado
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

6.  Short-term cost-utility of degludec versus glargine U100 for patients with type 2 diabetes at high risk of hypoglycaemia and cardiovascular events: A Canadian setting (DEVOTE 9).

Authors:  Richard F Pollock; Simon Heller; Thomas R Pieber; Vincent Woo; Jens Gundgaard; Nino Hallén; Maria Luckevich; Deniz Tutkunkardas; Bernard Zinman
Journal:  Diabetes Obes Metab       Date:  2019-04-14       Impact factor: 6.577

7.  Implementing Low-Cost, Community-Based Exercise Programs for Middle-Aged and Older Patients with Type 2 Diabetes: What Are the Benefits for Glycemic Control and Cardiovascular Risk?

Authors:  Romeu Mendes; Nelson Sousa; Victor Machado Reis; Jose Luis Themudo-Barata
Journal:  Int J Environ Res Public Health       Date:  2017-09-13       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.